Ionis Pharmaceuticals: Piper Sandler Keeps Overweight Rating, Raises PT to $77 from $70.

martes, 4 de noviembre de 2025, 11:46 am ET1 min de lectura
IONS--

Ionis Pharmaceuticals: Piper Sandler Keeps Overweight Rating, Raises PT to $77 from $70.

Ionis Pharmaceuticals: Piper Sandler Keeps Overweight Rating, Raises PT to $77 from $70.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios